UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Renin–angiotensin-system blockade in the prevention of diabetes

Diabetes research and clinical practice, 2007-05, Vol.76 (3), p.S13-S21

Ostergren, Jan

2007

Volltextzugriff (PDF)

Predictors of mortality and morbidity in patients with chronic heart failure

European heart journal, 2006-01, Vol.27 (1), p.65-75

2006

Volltextzugriff (PDF)

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure

European heart journal, 2008-06, Vol.29 (11), p.1377-1385

2008

Volltextzugriff (PDF)

Interruptions in emergency department work: an observational and interview study

BMJ quality & safety, 2013-08, Vol.22 (8), p.656-663

2013

Volltextzugriff (PDF)

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial

Journal of hypertension, 2001-06, Vol.19 (6), p.1139-1147

2001

Volltextzugriff (PDF)

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

The Lancet (British edition), 2005-09, Vol.366 (9489), p.907-913

2005

Volltextzugriff (PDF)

Changes in cardiac output, rhythm regularity, and symptom severity after electrical cardioversion of atrial fibrillation (Vol 57, 2236341, 2023)

SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2024-12, Vol.58 (1)

2024

Volltextzugriff (PDF)

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

European heart journal, 2013, Vol.34 (39), p.3035

2013

Volltextzugriff (PDF)

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases

European heart journal, 2011-11, Vol.32 (22), p.2851-2906

2011

Volltextzugriff (PDF)

Significant changes in emergency department length of stay and case mix over eight years at a large Swedish University Hospital

International emergency nursing, 2019-03, Vol.43, p.50-55

2019

Volltextzugriff (PDF)

Hypertension is a clinical problem ... even though we have tools to solve it

Läkartidningen, 2012-09, Vol.109 (36), p.1544-1548

Ostergren, Jan

2012

Volltextzugriff (PDF)

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

European heart journal, 2007-01, Vol.28 (1), p.88-136

2007

Volltextzugriff (PDF)

Use of ramipril in preventing stroke: double blind randomised trial

BMJ, 2002-03, Vol.324 (7339), p.699-699

International edition, 2002

Volltextzugriff (PDF)

Factors influencing clinicians' perceptions of interruptions as disturbing or non-disturbing: A qualitative study

International emergency nursing, 2016-07, Vol.27, p.11-16

2016

Volltextzugriff (PDF)

Medical errors and complaints in emergency department care in Sweden as reported by care providers, healthcare staff, and patients - a national review

European journal of emergency medicine, 2013-02, Vol.20 (1), p.33-38

2013

Volltextzugriff (PDF)

Reasons for interrupting colleagues during emergency department work – A qualitative study

International emergency nursing, 2016-11, Vol.29 (SI), p.21-26

2016

Volltextzugriff (PDF)

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

EUROPEAN HEART JOURNAL, 2014-07, Vol.35 (27), p.1824-1824

2014

Volltextzugriff (PDF)

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text

European heart journal supplements, 2007-06, Vol.9 (suppl-C), p.C3-C74

2007

Volltextzugriff (PDF)

Angiotensin receptor blockers in the prevention and management of diabetes and its complications -: Introduction

Diabetes research and clinical practice, 2007, Vol.76, p.S1

Ostergren, J

2007

Volltextzugriff (PDF)

Predictors of Development in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Diabetes care, 2009-05, Vol.32 (5), p.915

2009

Volltextzugriff (PDF)

Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes

Diabetes care, 2005-05, Vol.28 (5), p.1151-1157

2005

Volltextzugriff (PDF)

Impact of Cigarette Smoking in High-Risk Patients Participating in a Clinical Trial. A Substudy from the Heart Outcomes Prevention Evaluation (HOPE) Trial

European journal of cardiovascular prevention and rehabilitation, 2005-02, Vol.12 (1), p.75-81

2005

Volltextzugriff (PDF)

Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and design

Journal of cardiac failure, 1999-09, Vol.5 (3), p.276-282

1999

Volltextzugriff (PDF)

Resource utilization and costs in the Candesartan in Heart failure : Assessment of Reduction in Mortality and morbidity (CHARM) programme

European heart journal, 2006-06, Vol.27 (12), p.1447-1458

2006

Volltextzugriff (PDF)

Dual Renin-Angiotensin System Blockade in Heart Failure

Journal of the American College of Cardiology, 2009-07, Vol.54 (3), p.278-278

2009

Volltextzugriff (PDF)

1 – 25 von 129

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieEuropean Journal Of Heart Failure

SpracheJapanisch

ThemaFemale

ThemaPeripheral Vascular Disease

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(121)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Renin–angiotensin-system blockade in the prevention of diabetes

Predictors of mortality and morbidity in patients with chronic heart failure

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure

Interruptions in emergency department work: an observational and interview study

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

Changes in cardiac output, rhythm regularity, and symptom severity after electrical cardioversion of atrial fibrillation (Vol 57, 2236341, 2023)

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases

Significant changes in emergency department length of stay and case mix over eight years at a large Swedish University Hospital

Hypertension is a clinical problem ... even though we have tools to solve it

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

Use of ramipril in preventing stroke: double blind randomised trial

Factors influencing clinicians' perceptions of interruptions as disturbing or non-disturbing: A qualitative study

Medical errors and complaints in emergency department care in Sweden as reported by care providers, healthcare staff, and patients - a national review

Reasons for interrupting colleagues during emergency department work – A qualitative study

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text

Angiotensin receptor blockers in the prevention and management of diabetes and its complications -: Introduction

Predictors of Development in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes

Impact of Cigarette Smoking in High-Risk Patients Participating in a Clinical Trial. A Substudy from the Heart Outcomes Prevention Evaluation (HOPE) Trial

Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and design

Resource utilization and costs in the Candesartan in Heart failure : Assessment of Reduction in Mortality and morbidity (CHARM) programme

Dual Renin-Angiotensin System Blockade in Heart Failure

Aktive Filter

Suchergebnisse filtern